Although SIX1 expression was significantly increased in pathological stages 3 and 4 compared to pathological stage 1 in liver and colon cancer samples, a significant increase was detected only in stage 4 compared to stage 1 in breast cancer (Figure 1B). This evidence concerns the gene SIX1 and breast carcinoma.